S Z Langer

4.3k total citations · 2 hit papers
48 papers, 3.5k citations indexed

About

S Z Langer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, S Z Langer has authored 48 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 16 papers in Physiology. Recurrent topics in S Z Langer's work include Receptor Mechanisms and Signaling (21 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). S Z Langer is often cited by papers focused on Receptor Mechanisms and Signaling (21 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). S Z Langer collaborates with scholars based in France, Argentina and United States. S Z Langer's co-authors include U. Trendelenburg, Margarita L. Dubocovich, María Amelia Enero, Anne‐Marie Galzin, Michael S. Briley, John Lehmann, I. Angel, Paul R. Draskóczy, B. Scatton and Carlos Rubio-Terrés and has published in prestigious journals such as The Journal of Physiology, Trends in Neurosciences and Pharmacological Reviews.

In The Last Decade

S Z Langer

46 papers receiving 3.1k citations

Hit Papers

Presynaptic regulation of the release of catecholamines. 1977 2026 1993 2009 1980 1977 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Z Langer France 25 2.0k 2.0k 798 461 233 48 3.5k
L. Stjärne Sweden 35 2.1k 1.0× 2.2k 1.1× 855 1.1× 467 1.0× 316 1.4× 161 3.7k
Bradley V. Clineschmidt United States 32 2.1k 1.0× 1.8k 0.9× 879 1.1× 303 0.7× 364 1.6× 86 3.8k
W. Kobinger Austria 32 1.5k 0.7× 1.6k 0.8× 637 0.8× 830 1.8× 195 0.8× 104 3.3k
Ewan J. Mylecharane Australia 18 2.5k 1.2× 2.0k 1.0× 866 1.1× 259 0.6× 301 1.3× 39 4.2k
G. Engel Germany 23 2.2k 1.1× 2.0k 1.0× 651 0.8× 180 0.4× 178 0.8× 55 3.6k
R. Laverty New Zealand 28 2.1k 1.0× 1.1k 0.6× 708 0.9× 235 0.5× 214 0.9× 89 3.7k
Thomas C. Westfall United States 33 2.4k 1.2× 1.9k 0.9× 779 1.0× 372 0.8× 565 2.4× 102 3.9k
David B. Bylund United States 32 2.4k 1.1× 2.3k 1.2× 670 0.8× 199 0.4× 201 0.9× 89 4.1k
G. Hertting Germany 30 1.7k 0.8× 1.5k 0.8× 517 0.6× 325 0.7× 148 0.6× 136 3.3k
B. P. Richardson United Kingdom 15 1.5k 0.8× 1.4k 0.7× 786 1.0× 157 0.3× 150 0.6× 31 3.0k

Countries citing papers authored by S Z Langer

Since Specialization
Citations

This map shows the geographic impact of S Z Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Z Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Z Langer more than expected).

Fields of papers citing papers by S Z Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Z Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Z Langer. The network helps show where S Z Langer may publish in the future.

Co-authorship network of co-authors of S Z Langer

This figure shows the co-authorship network connecting the top 25 collaborators of S Z Langer. A scholar is included among the top collaborators of S Z Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Z Langer. S Z Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Granger, P., Bruno Biton, Christophe Fauré, et al.. (1995). Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.. Molecular Pharmacology. 47(6). 1189–1196. 121 indexed citations
2.
Langer, S Z & I. Angel. (1991). Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery. PubMed. 34. 171–177. 8 indexed citations
3.
Blier, Pierre, Anne‐Marie Galzin, & S Z Langer. (1990). Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 236–244. 20 indexed citations
4.
Langer, S Z & S. Arbilla. (1990). Presynaptic Receptors on Peripheral Noradrenergic Neurons. Annals of the New York Academy of Sciences. 604(1). 7–16. 14 indexed citations
5.
Angel, I., et al.. (1990). Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.. Journal of Pharmacology and Experimental Therapeutics. 254(3). 883–887. 54 indexed citations
6.
Galzin, Anne‐Marie, et al.. (1988). Day–night rhythm of 5-methoxytryptamine biosynthesis in the pineal gland of the golden hamster (Mesocricetus auratus). Journal of Endocrinology. 118(3). 389–397. 35 indexed citations
7.
Graham, David Y. & S Z Langer. (1987). [3H]tryptamine binding sites of rat cerebral cortex: Pharmacological profile and plasticity. Neuropharmacology. 26(8). 1093–1097. 18 indexed citations
8.
Galzin, Anne‐Marie & S Z Langer. (1985). Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.. Journal of Pharmacology and Experimental Therapeutics. 233(2). 459–465. 3 indexed citations
9.
Galzin, Anne‐Marie, Chantal Moret, & S Z Langer. (1984). Evidence that exogenous but not endogenous norepinephrine activates the presynaptic alpha-2 adrenoceptors on serotonergic nerve endings in the rat hypothalamus.. Journal of Pharmacology and Experimental Therapeutics. 228(3). 725–732. 60 indexed citations
10.
Lehmann, John, Michael S. Briley, & S Z Langer. (1983). Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists. European Journal of Pharmacology. 88(1). 11–26. 116 indexed citations
11.
Dubocovich, Margarita L. & S Z Langer. (1980). Dopamine and alpha adrenoceptor agonists inhibit neurotransmission in the cat spleen through different presynaptic receptors.. Journal of Pharmacology and Experimental Therapeutics. 212(1). 144–152. 73 indexed citations
12.
Dubocovich, Margarita L., S Z Langer, & Chantal Moret. (1979). Antagonism by (+)-amphetamine of the inhibition of [3H]-noradrenaline overflow obtained by alpha-adrenoceptor agonists or bretylium in the perfused cat spleen [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 66(3). 460P–461P. 3 indexed citations
13.
Arbilla, S. & S Z Langer. (1978). Effects of gamma-aminobutyric acid on the potassium and tyramine induced release of [3Hi1-noradrenaline from rat occipital cortex slices [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 389P–390P. 1 indexed citations
14.
Dubocovich, Margarita L., et al.. (1978). Effect of cyclic nucleotides on [3H]-neurotransmitter release induced by potassium stimulation in the rat pineal gland [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(3). 383P–384P. 1 indexed citations
15.
Langer, S Z, et al.. (1977). Subsensitivity of the presynaptic alpha adrenoceptors after short-term surgical denervation of the cat nictitating membrane.. Journal of Pharmacology and Experimental Therapeutics. 202(3). 610–621. 13 indexed citations
17.
Langer, S Z, F. J. E. Stefano, & María Amelia Enero. (1972). PRE- AND POSTSYNAPTIC ORIGIN OF THE NOREPINEPHRINE METABOLITES FORMED DURING TRANSMITTER RELEASE ELICITED BY NERVE STIMULATION. Journal of Pharmacology and Experimental Therapeutics. 183(1). 90–102. 24 indexed citations
18.
Adler‐Graschinsky, Edda, S Z Langer, & Carlos Rubio-Terrés. (1972). METABOLISM OF NOREPINEPHRINE RELEASED BY PHENOXYBENZAMINE IN ISOLATED GUINEA-PIG ATRIA. Journal of Pharmacology and Experimental Therapeutics. 180(2). 286–301. 67 indexed citations
19.
Jarrott, Bevyn & S Z Langer. (1971). Changes in monoamine oxidase and catechol‐o‐methyl transferase activities after denervation of the nictitating membrane of the cat. The Journal of Physiology. 212(2). 549–559. 17 indexed citations
20.
Langer, S Z & U. Trendelenburg. (1968). DECREASE IN EFFECTIVENESS OF PHENOXYBENZAMINE AFTER CHRONIC DENERVATION AND CHRONIC DECENTRALIZATION OF THE NICTITATING MEMBRANE OF THE PITHED CAT. Journal of Pharmacology and Experimental Therapeutics. 163(2). 290–299. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026